Clinical trial

Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes

NCT01536652

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2006-01-01

PhaseN/A

Study timeline

Study start (unknown)2006-01-01Date precision: month

Registry last updated2016-03-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

biphasic insulin aspart 30DRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

MainzGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01536652 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.